Evidence map›Paper›PMID 8627737›Full record

ArticleJournal of virology1996

Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU.

S Valsesia-Wittmann, F J Morling, B H Nilson, Y Takeuchi, S J Russell, F L Cosset

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types.Proceedings of the National Academy of Sciences of the United States of America · 1999
    Article
  14. Article
  15. Article
  16. Article
  17. Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein.Proceedings of the National Academy of Sciences of the United States of America · 1998
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

S Valsesia-WittmannCentre de Génétique Moléculaire et Cellulaire, Université Claude Bernard Lyon-I, United Kingdom.
F J Morling
B H Nilson
Y Takeuchi
S J Russell
F L Cosset
Université Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously reported a strategy to redirect the retroviral host range by expressing single-chain antibodies (S. J. Russell, R. E. Hawkins, and G. Winter, Nucleic Acids Res. 21:1081-1085, 1993) or ligands (F.-L. Cosset, F. J Morling, Y. Takeuchi, R. A. Weiss, M. K. L. Collins, and S. J. Russell, J. Virol. 69:6314-6322, 1995) at the N terminus of Moloney murine leukemia virus (MoMLV) surface proteins (SU). Although such chimeric envelopes were able to bind the new receptors, the transduction efficiency of retargeted viruses was generally low. We hypothesized that conformational rearrangements of envelope glycoproteins were not optimally triggered following binding, and to overcome these postbinding blocks, we have generated here a set of chimeric MoMLV-derived envelopes targeted to the Ram-1 phosphate transporter in which we have varied the spacing between the Ram-1-binding domain and the MoMLV SU. All of the recombinant envelopes were correctly expressed on virions, and all bound efficiently to Ram-1. However, the interdomain spacing greatly affected the efficiency of gene transfer by retroviral vectors that had bound to Ram-1 via their chimeric envelopes. Optimal interdomain spacing allowed a 100-fold-increased viral transduction via Ram-1 compared to our previous results.

Indexed as

Phosphate Transport ProteinsSymporters3T3 CellsAnimalsBase SequenceCell LineCloning, MolecularDNA, ViralHumansMiceMolecular Sequence DataMoloney murine leukemia virusMutagenesisReceptors, VirusRecombinant Fusion ProteinsRetroviridae Proteins, OncogenicDNA, ViralPhosphate Transport ProteinsReceptors, VirusRecombinant Fusion ProteinsRetroviridae Proteins, OncogenicSlc20a2 protein, mouseSodium-Phosphate Cotransporter ProteinsSodium-Phosphate Cotransporter Proteins, Type IIISymportersViral Envelope Proteins

Identifiers

PMID8627737
PMCPMC190040
OpenAlexW1817684312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.